Personalizing Personalized Medicine - What we do know can help us!
Genomic research reached a major milestone with the Human Genome Project completion in 2003. This international research effort determined the DNA sequence of an entire reference human genome. The result was renewed interest in what is now called Personalized Medicine, an approach that includes information about each person’s unique genetic makeup. As straightforward as it is these days to have your own genome mapped, the challenge is to determine what to do with the information. People are often more fearful of the negative implications of their 22,000 genes than any sense of benefit it might offer.
Working at the crossroads of genetic research, personalized medicine, and big data, is entrepreneur and genetic researcher, Dr. Fredric Abramson. Dr. Abramson is tapping into the most individualized data– your genotype – and delivering those data via platforms that enable people to make smarter lifestyle decisions. He is taking a much broader approach to determining how our personal genetic make-up impacts everything from the medication we are prescribed to the food we eat, the vitamins we take, our lifestyle, and the environment we live in. Knowledge of how all of these things interact with each of us specifically could lead to a healthier, happier, and more productive life. A key element to Dr. Abramson’s approach is to focus on genetic variation that influences normal, everyday functions. Everyone knows that we inherit talents, traits and tendencies that impact our creativity, athletic ability, metabolism and weight management, and personality, as a few examples. Dr. Abramson refers to these genetic markers as our “genetic assets”, to distinguish them from disease-related genes, which are the “genetic liabilities.”
Dr. Abramson’s background is a rare combination of business, science and technology. He received an A.B. in Mathematical Biology from Penn, a Ph.D. in Human Genetics and Population Planning from Michigan, and he is an MIT Sloan Fellow Masters of Management. He is a patent attorney admitted to the U.S. Supreme Court. He advised Federal and State governments on policies regarding alcohol abuse, science experiments in space, nuclear reactor inspector objectivity, and worker’s compensation. For 19 years, Johns Hopkins has engaged Dr. Abramson to teach economics, finance and business to Biotechnology Master’s students. He likewise has a broad spectrum of applied business experience. Pertinent to our GPSEG program, he is the Chair of non-profit Fresh Start Science that combines wellness genetics information with supportive mentoring/coaching and community resource access to help young single mothers. He is also the founder of Digital Nutrition, LLC developing a product that will let users scan a vitamin product code in the store and receive a score on how closely that specific product matches the person's genetic makeup.
Join us at GPSEG Life Sciences Biotech program in March for an intriguing presentation by Dr. Fredric Abramson, genetic entrepreneur, on Personalizing Personalized Medicine.